A Prospective Phase I Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ as a Treatment for Arthritis of the Basal Thumb Joint

Trial Profile

A Prospective Phase I Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ as a Treatment for Arthritis of the Basal Thumb Joint

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2016

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 11 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 04 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
    • 29 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top